Comparison of Topical Pigment Epithelium-Derived Factor (PEDF) with Topical Bevacizumab for Accelerating the Regression of Corneal Neovascularization in an Experimental Model of Rabbit Corneal Angiogenesis

Corneal neovascularization and contemporary antiangiogenic therapeutics

(2015) Chih-Chien Hsu et al.   Journal of the Chinese Medical Association

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization

(2014) Wei-Li Chen et al.   PLoS One

Inhibition of Corneal Neovascularization by Subconjunctival and Topical Bevacizumab and Sunitinib in a Rabbit Model

(2013) Byung-Yi Ko et al.   CORNEA

Anti-VEGF Therapy (Bevacizumab) for Sulfur Mustard-Induced Corneal Neovascularization Associated with Delayed Limbal Stem Cell Deficiency in Rabbits

(2013) Tamar Kadar et al.   CURRENT EYE RESEARCH

Inhibition of Corneal Neovascularization with the Combination of Bevacizumab and Plasmid Pigment Epithelium-Derived Factor-Synthetic Amphiphile INTeraction-18 (p-PEDF-SAINT-18) Vector in a Rat Corneal Experimental Angiogenesis Model

(2013) Chien-Neng Kuo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization

(2012) Sheng-Fu Cheng et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

(2012) Constantinos Petsoglou et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Effects of Subconjunctival Bevacizumab on Corneal Neovascularization

(2012) Yohan Benayoun et al.   CORNEA

PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression

(2012) Takanori Matsui et al.   MICROVASCULAR RESEARCH

Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin)

(2012) William Stevenson et al.   Ocular Surface

Topical and Subconjunctival Bevacizumab for Corneal Neovascularization in an Experimental Rat Model

(2012) Veysi Öner et al.   OPHTHALMIC RESEARCH

Long-Term Retinal PEDF Overexpression Prevents Neovascularization in a Murine Adult Model of Retinopathy

(2012) Virginia Haurigot et al.   PLoS One

Overexpression of Pigment Epithelium–Derived Factor Inhibits Retinal Inflammation and Neovascularization

(2011) Kyoungmin Park et al.   AMERICAN JOURNAL OF PATHOLOGY

Combined Use of Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization

(2011) Sonia N Yeung et al.   CORNEA

Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease

(2011) Hamid Hosseini et al.   CORNEA

Prevention of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Its Topical Form in Experimental Rats

(2011) Mohammad Naser Hashemian et al.   OPHTHALMIC RESEARCH

The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization

(2009) Zohar Habot-Wilner et al.   ACTA OPHTHALMOLOGICA

Subconjunctival Bevacizumab Injection for Corneal Neovascularization

(2009) Irit Bahar et al.   CORNEA

Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis

(2009) Chien-Neng Kuo et al.   EXPERIMENTAL EYE RESEARCH

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

(2009) Yanyan Koenig et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Reduction of Endogenous Angiogenesis Inhibitors in Bruch's Membrane of the Submacular Region in Eyes With Age-Related Macular Degeneration

(2008) Imran A. Bhutto   ARCHIVES OF OPHTHALMOLOGY

Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization

(2008) Young Sang Han et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

The Effect of Topical Bevacizumab on Corneal Neovascularization

(2008) Sang Woo Kim et al.   OPHTHALMOLOGY